OVERVIEW
The Global Stem Cell Banking Market is expected to hit USD 10.67 billion by 2025, rising by 7.65% to CAGR during the forecast period. Factors such as growing awareness on the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing and storage; increase in hematopoietic stem cell transplantation (HSCT) procedures; and increasing investments in stem cell-based research are driving demand for Stem Cell Banking Market.
TABLE OF CONTENT
1 Global Stem Cell Banking Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Stem Cell Banking Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Stem Cell Banking Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Stem Cell Banking Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Stem Cell Banking Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Stem Cell Banking Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Stem Cell Banking Market – By Service Type (Market Size – & million/billion)
8.1 Sample Preservation and Storage
8.2 Sample Analysis
8.3 Sample Processing
8.4 Sample Collection and Transportation
9 Global Stem Cell Banking Market – By Source
9.1 Placental Stem Cells (PSCS)
9.2 Adipose Tissue-Derived Stem Cells (ADSCS)
9.3 Bone Marrow-Derived Stem Cells (BMSCS)
9.4 Human Embryo-Derived Stem Cells (HESCS)
9.5 Dental Pulp-Derived Stem Cells (DPSCS)
9.6 Others
10 Global Stem Cell Banking Market – By Application
10.1 Personalized Banking Applications
10.2 Research Applications
10.3 Clinical Application
11 Global Stem Cell Banking Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Stem Cell Banking Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Stem Cell Banking Market – Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Cord Blood Registry Systems
13.3 Cordlife
13.4 Cryo-Cell International
13.5 Global Cord Blood
13.6 Smart Cells International
13.7 Vita34
13.8 Cryo-Save AG (A Subsidiary of Esperite N.V)
13.9 LifeCell International
13.10 StemCyte
13.11 ViaCord (A Subsidiary of Perkinelmer)
13.12 Company 11 & more
14 Global Stem Cell Banking Market – Appendix
14.1 Sources
14.2 Abbreviations